{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "A Randomised Controlled Trial on Extracellular Vesicles in PRBC Transfusion"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "prospective subanalysis of a recent observational feasibility study"
      },
      "Participants": {
        "score": 2,
        "evidence": "23 postoperative ICU patients: 5 after open aortic surgery, 9 after bilateral lung transplantation, and 9 after other surgeries. Eligibility criteria were age 18-99 years and PRBC transfusion postoperatively."
      },
      "Intervention": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Objective": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Method_Outcome": {
        "score": 1,
        "evidence": "EVs were analyzed using flow cytometry."
      },
      "Randomisation_Allocation": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Blinding": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "23 postoperative ICU patients"
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "Total EVs, EryEVs, total PEVs, and GEVs increased post-transfusion compared to baseline in the entire cohort."
      },
      "Harms": {
        "score": 1,
        "evidence": "No adverse events were reported."
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "Clinicaltrials.gov: NCT03782623."
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: Not specified."
      }
    },
    "total_score": 10,
    "max_score": 25
  },
  "model": "gpt-4o"
}